RPID · Rapid Micro Biosystems, Inc. · Executive Compensation
Market Cap
$39.12M
Shares
50.16M
Volume · Oct 26
35.06K
Avg daily vol (3M)
242.94K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Robert Spignesi | Chief Executive Officer | $3,225,491 |
| Robert G. Spignesi | Chief Executive Officer | $3,225,491 |
| Sean Wirtjes | Chief Financial Officer | $1,589,310 |
| John Wilson | Chief Operating Officer | $1,062,736 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Robert Spignesi | Chief Executive Officer | $1,313,638 |
| Robert G. Spignesi | Chief Executive Officer | $1,313,638 |
| Sean Wirtjes | Chief Financial Officer | $762,893 |
| John Wilson | Chief Operating Officer | $725,767 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Robert G. Spignesi | Chief Executive Officer | $1,797,254 |
| Robert Spignesi | Chief Executive Officer | $1,797,254 |
| John Wilson | Chief Operating Officer | $957,949 |
| Sean Wirtjes | Chief Financial Officer | $923,838 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Robert G. Spignesi | Chief Executive Officer | $2,223,984 |
| Robert Spignesi | Chief Executive Officer | $2,223,984 |
| John Wilson | Chief Operating Officer | $1,410,104 |
| Sean Wirtjes | Chief Financial Officer | $1,096,542 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Richard Keys | Chief Commercial Officer | $1,637,678 |
| Robert G. Spignesi | Chief Executive Officer | $1,459,538 |
| Robert Spignesi | Chief Executive Officer | $1,459,538 |
| John Wilson | Chief Operating Officer | $1,220,591 |
| Sean Wirtjes | Chief Financial Officer | $670,093 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Robert Spignesi | Chief Executive Officer | $1,090,832 |
| Robert G. Spignesi | Chief Executive Officer | $1,090,832 |
| Sean Wirtjes | Chief Financial Officer | $613,828 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Robert Spignesi | principal operating officer | Appointed | 2026-03-27 |
| Jeffrey Schwartz | board of directors | Resigned | 2025-05-23 |
| David Hirsch, M.D., Ph.D. | Class I director | Resigned | 2024-11-01 |
| David Hirsch, M.D., Ph.D. | Chair of the Compensation Committee | Resigned | 2023-07-18 |
| Jeffrey Schwartz | Chair of the Board | Resigned | 2023-07-18 |
| Kirk D. Malloy, Ph.D. | Class III member of the Board | Appointed | 2023-07-18 |
| Kirk D. Malloy, Ph.D. | Class III member of the Board and Chair of the Board | Appointed | 2023-07-18 |
| Richard Keys | Chief Commercial Officer | Terminated | 2022-08-12 |
Leadership
- Robert G. Spignesi CEO, Board Member
- Robert Spignesi CEO, Board Member
- Kirk D. Malloy, Ph.D. Chairman, Board Member
- Sean Wirtjes CFO
- Jonathan Paris General Counsel
- Dafni Bika Board Member
- Inese Lowenstein Board Member
- Kirk D. Malloy Board Member
- Melinda Litherland Board Member
- Natale Ricciardi Board Member
- Richard Kollender Board Member
Key facts
CIK
1380106
CUSIP
75340L104
13F (30d)
22 filings
5 filers
Visit website
Investor relations